Xperi Corporation Announces Third Quarter 2018 Results
“During the third quarter, we delivered billings in line with our expectations and managed operating expenses below the low end of our range, resulting in better-than-expected profitability. In product licensing, we announced a significant strategic partnership with
Financial Highlights
($ and share count in thousands)
GAAP | Non-GAAP | ||||||||||||
Q3 2018 | Q3 2017 | Q3 2018 | Q3 2017 | ||||||||||
Billings 1 |
$ | 100,587 | $ | 85,308 | $ | 100,587 | $ | 85,308 | |||||
Total Operating Expense 2 |
$ | 92,126 | $ | 98,434 | $ | 57,465 | $ | 58,642 | |||||
Interest Expense 1 |
$ | 6,343 | $ | 7,371 | $ | 6,343 | $ | 7,371 | |||||
Other Income / (Expense) 2 |
$ | 1,737 | $ | 739 | $ | 160 | $ | 739 | |||||
Cash Tax Payments 1 |
$ | 4,462 | $ | 4,405 | $ | 4,462 | $ | 4,405 | |||||
Diluted Shares Outstanding | 48,958 | 49,469 | 51,776 | 52,794 |
1 | Measures are the same for both the GAAP and Non-GAAP presentation. | |
2 | See tables for reconciliations. | |
Other Relevant Metrics | Q3 2018 | Q3 2017 | ||||
Operating Cash Flow 1 | $ | 29,398 | $ | 39,967 | ||
Cash, Cash Equivalents, S-T Investments and Restricted Cash | $ | 105,435 | $ | 157,300 |
1 | Q3 2017 operating cash flow includes receipt of a late customer payment of approximately $11 million that should have been received in Q2 2017. Q3 2018 operating cash flow was impacted by approximately $6 million in billings invoiced late in Q3, most of which has already been collected in Q4. | |
Stock Repurchase Program
During the third quarter of 2018, the Company repurchased approximately 461 thousand shares of common stock for an aggregate amount of
Dividends
On
Additionally, on
Financial Guidance
Consequent with the introduction of the new revenue accounting standard, ASC 606, the Company announced it would begin using billings as a key measure of business progress. As a result, the Company’s outlook is now based on billings rather than GAAP revenue. For additional information regarding the Company’s approach to guidance, please review the “ASC 606 Business Metrics and Guidance Approach” presentation given by the Company on
Q4 2018 |
GAAP Outlook |
Non-GAAP Outlook |
||||
Billings 1 |
$109M to 124M | $109M to 124M | ||||
Operating Expense |
$95M to 99M | $59M to 63M |
1 | Measures are the same for both the GAAP and Non-GAAP presentation. | |
The Company is lowering the high end of its fiscal year 2018 billings range to reflect greater visibility at this point in the year and updated timing and risk adjustments associated with the Semiconductor and IP Licensing forecast. The Company is also reducing its operating expense outlook for the year and adjusting down its diluted share count due to buybacks. Additionally, the Company is updating its operating cash flow outlook to reflect changes in billings and expenses, and balance sheet movements.
The revised 2018 outlook is as follows:
FY 2018 |
GAAP Outlook |
Non-GAAP Outlook |
||||
Billings 1 |
$415M to 430M | $415M to 430M | ||||
Operating Expense |
$377M to 381M | $235M to 239M | ||||
Cash Tax Payments 1 |
$16M to 20M | $16M to 20M | ||||
Fully Diluted Shares |
49.0M | 52.0M | ||||
Operating Cash Flow 1 |
$120M to 130M | $120M to 130M |
1 | Measures are the same for both the GAAP and Non-GAAP presentation. | |
Conference Call Information
The Company will hold its third quarter 2018 earnings conference call at
Safe Harbor Statement
This press release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ significantly from those projected, particularly with respect to the Company’s financial results and guidance, the expected benefits of the Company’s strategic partnership with
The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included herein and elsewhere, including the Risk Factors included in the Company's recent reports on Form 10-K and Form 10-Q and other documents of the Company on file with the
About
Billings
Billings reflect amounts in an accounting period invoiced to customers, less any credits issued to or paid to customers, plus amounts due under certain licensing-related contractual arrangements that may not be subject to an invoice. Management evaluates the Company’s financial performance in part based on billings due to the close alignment between billings and cash receipts from licensing activity, and believes billings is an important metric to provide to readers of our financial results. Billings may vary materially from revenue recorded under U.S. GAAP.
Non-GAAP Financial Measures
In addition to disclosing financial results calculated in accordance with U.S. Generally Accepted Accounting Principles (GAAP), the Company’s earnings release contains non-GAAP financial measures adjusted for either one-time or ongoing non-cash acquired intangibles amortization charges, acquired in-process research and development, all forms of stock-based compensation, restructuring and other related exit costs. Management believes that the non-GAAP measures used in this release provide investors with important perspectives into the Company’s ongoing business performance. The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated. The non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. All financial data is presented on a GAAP basis except where the Company indicates its presentation is on a non-GAAP basis.
Set forth below are reconciliations of the Company’s reported GAAP to non-GAAP financial metrics.
XPER-E
XPERI CORPORATION | ||||||||||
FINANCIAL INFORMATION SCHEDULE | ||||||||||
COMPONENTS OF GAAP AND NON-GAAP OPERATING EXPENSE |
||||||||||
(in thousands) | ||||||||||
(unaudited) | ||||||||||
Three Months Ended | ||||||||||
September 30, | ||||||||||
2018 | 2017 | |||||||||
GAAP operating expense - components | ||||||||||
Cost of revenue | $ | 5,003 | $ | 1,667 | ||||||
Research, development and other related costs | 24,189 | 25,840 | ||||||||
Selling, general and administrative | 28,084 | 33,995 | ||||||||
Amortization expense | 27,208 | 27,769 | ||||||||
Litigation expense | 7,642 | 9,163 | ||||||||
Total operating expenses | $ | 92,126 | $ | 98,434 | ||||||
Three Months Ended | ||||||||||
September 30, | ||||||||||
2018 | 2017 | |||||||||
Non-GAAP operating expense - components | ||||||||||
Cost of revenue | $ | 5,003 | $ | 1,667 | ||||||
Research, development and other related costs | 20,937 | 21,712 | ||||||||
Selling, general and administrative | 23,883 | 26,100 | ||||||||
Litigation expense | 7,642 | 9,163 | ||||||||
Total operating expenses | $ | 57,465 | $ | 58,642 | ||||||
XPERI CORPORATION | ||||||||||
RECONCILIATION FROM GAAP TO NON-GAAP OPERATING EXPENSES | ||||||||||
(in thousands) | ||||||||||
(unaudited) | ||||||||||
Three Months Ended | ||||||||||
September 30, | ||||||||||
2018 | 2017 | |||||||||
GAAP operating expenses | $ | 92,126 | $ | 98,434 | ||||||
Adjustments to non-GAAP operating expenses: | ||||||||||
Stock-based compensation --R&D | (3,252 | ) | (3,290 | ) | ||||||
Stock-based compensation --SG&A | (4,201 | ) | (5,086 | ) | ||||||
Amortization expense | (27,208 | ) | (27,769 | ) | ||||||
Acquisition & related expense--R&D | — | (838 | ) | |||||||
Acquisition & related expense--SG&A | — | (2,809 | ) | |||||||
Non-GAAP operating expenses | $ | 57,465 | $ | 58,642 | ||||||
XPERI CORPORATION | ||||||||||
RECONCILIATION FROM GAAP TO NON-GAAP OTHER INCOME/(EXPENSE) | ||||||||||
(in thousands) | ||||||||||
(unaudited) | ||||||||||
Three Months Ended | ||||||||||
September 30, | ||||||||||
2018 | 2017 | |||||||||
GAAP other income/(expense) | $ | 1,737 | $ | 739 | ||||||
Adjustments to non-GAAP other income/(expense): | ||||||||||
Interest income from significant financing components under Topic 606 | (1,577 | ) | — | |||||||
Non-GAAP other income/(expense) | $ | 160 | $ | 739 | ||||||
XPERI CORPORATION | ||||||||||||||||
RECONCILIATION FOR GUIDANCE ON | ||||||||||||||||
GAAP TO NON-GAAP OPERATING EXPENSE | ||||||||||||||||
(in millions) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three months ended | Year ended | |||||||||||||||
December 31, 2018 | December 31, 2018 | |||||||||||||||
Low | High | Low | High | |||||||||||||
GAAP expense | $ | 95 | $ | 99 | $ | 377 | $ | 381 | ||||||||
Stock-based compensation--R&D | (4 | ) | (4 | ) | (14 | ) | (14 | ) | ||||||||
Stock-based compensation--SG&A | (5 | ) | (5 | ) | (17 | ) | (17 | ) | ||||||||
Acquisition & related expense | — | — | (3 | ) | (3 | ) | ||||||||||
Amortization expense | (27 | ) | (27 | ) | (108 | ) | (108 | ) | ||||||||
Total of non-GAAP adjustments | (36 | ) | (36 | ) | (142 | ) | (142 | ) | ||||||||
Non-GAAP expense | $ | 59 | $ | 63 | $ | 235 | $ | 239 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20181107005811/en/
Source:
Xperi PR:
Jordan Miller, +1 818-436-1082
jordan.miller@xperi.com
or
Xperi Investor Relations:
Geri Weinfeld, +1 818-436-1231
geri.weinfeld@xperi.com